04/28/2025
2:38 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
12:36 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
12:37 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
12:37 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
12:38 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:07 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
4:30 PM | Cumberland Pharmaceuticals (Filer)
| Form ARS | |
03/18/2025
4:11 PM | Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:11 PM | Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:12 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:13 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CPIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/18/2025
4:14 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:15 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:15 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:06 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:09 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:10 PM | Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:00 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/10/2025
4:01 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
03/07/2025
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
4:26 PM | Cumberland Pharmaceuticals (Subject)
KAZIMI A J (Filed by)
| Form SCHEDULE 13G | |
02/04/2025
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
3:38 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4/A | |
01/30/2025
3:39 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4/A | |
01/30/2025
3:39 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4/A | |
01/30/2025
3:40 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4/A | |
12/30/2024
6:41 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:44 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:45 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:47 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
4:02 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:03 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:05 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
4:12 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:38 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
11/04/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:06 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:07 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:08 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:31 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
9:42 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:29 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:40 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:42 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:07 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
4:33 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:31 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:14 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy CPIX Stock Free CPIX Stock Alerts